期刊文献+

雷尼替丁治疗非典型抗精神病药所致体重增加疗效研究 被引量:5

Effect study for ranitidine in treatment of atypical antipsychotics-induced weight gain
下载PDF
导出
摘要 目的:探讨雷尼替丁治疗非典型抗精神病药物所致体重增加的疗效。方法:对非典型抗精神病药物所致体重增加患者62例,在常规服用非经典抗精神病药物的同时给予雷尼替丁治疗,疗程8 w,观察治疗前后体重、体重指数、腰围、臀围、腰/臀比值及胆固醇、三酰甘油的变化。结果:治疗8 w后体重、体重指数、腰围、臀围、腰/臀比值均较治疗前有极显著下降(P<0.01),TG、LDC-C、GIU均有显著下降(P<0.05),HDL-C显著升高(P<0.05)。结论:雷尼替丁对非经典抗精神病药物所致体重增加有显著的治疗效果,且不良反应少,安全性好。 Objective: To explore efficacy of ranitidine in treatment of atypical antipsychotics - induced weight gain. Methods:62 cases with atypical antipsychotics - induced weight gain were treated with ranitidine for 8 weeks besides the atypical antipsychotics. Body weight, body mass index, waist circumference, hip circumference, waist/hip ratio, cholesterol, and triglycerides were measured before and after the treatment. Results: After 8 weeks'treatment, the body weight, body mass index, waist circumference, hip circum- ference and waist/hip ratio decreased significantly compared with those before the treatment (P 〈 0.01 ) ; moreover, triglycerides, low density lipoprotein, blood glucose and GIU were significantly lower than those before the treatment (P 〈 0.05), whereas high density lipoprotein significantly increased(P 〈 0.05 ). Conclusions: Ranitidine for treating atypical antipsychotics -induced weight gain has the advantages of obvious effects, a few side effects, and good safety.
作者 房崇村
出处 《中国民康医学》 2013年第13期26-28,共3页 Medical Journal of Chinese People’s Health
关键词 雷尼替丁 非典型抗精神病药 体重增加 Ranitidine Atypical antipsychotics Weight gain
  • 相关文献

参考文献9

  • 1Allison DB, Caseu D. Antipsychotic induced weight gain. A review of the literature[ J ]. J Clin Psychiatry, 2001,62 ( suppl 7 ) : 22 - 31. 被引量:1
  • 2喻东山,主编.精神科合理用药手册[M].南京:江苏科学技术出版社,2006.35. 被引量:18
  • 3Casey DE, Zorn SH. The pharmachology of weight gain with antip- sychotics [ J ]. J Clin Psychiatry, 2001,62 ( suppl 7 ) : 5 - 7. 被引量:1
  • 4Baptista T. Body weight gain induced by antipsychotic drug: mech- anism and management[ J]. Acta Psychiatr Scand, 1999,100:3. 被引量:1
  • 5Wernake U ,Taylar D. Options for pharmacological management of obesity in patients treated with atypical antipsychoties [ J ]. Inter- national Clinical Psychopharmachology ,2002,17 : 145 - 160. 被引量:1
  • 6孙国兴.奥美拉唑治疗急性胰腺炎的临床疗效观察[J].中国现代药物应用,2008,2(20):37-38. 被引量:3
  • 7Stoa - Birketvedt G. Effect of cimetidine suspension on appetite Cimetidine and obesity;and weight in overweight subjects [ J ]. BMJ, 1993,306 (6885) : 1091. 被引量:1
  • 8Stoa - Birketvedt G. Waldum HL, Vonen B. Effect of cimetidine on basal and postprandial plasma concentrations of cholecystokinin and gastrin in humans [ J ]. Acta physiol Scand, 1997,159 (4) : 321. 被引量:1
  • 9Matson CA, Reid DF, Cannon TA, et al. Cholecystokinin and leptin act synergistically to reduce body weight [ J ]. AM J Physiol Regul Integr Comp Physoi1,2000,278 (4) :882. 被引量:1

二级参考文献1

  • 1[2]Bardhan KD,Naesdal J,Bianchi PG,et al.Treatment of refractory peptic ulcer with omeprazole.Gut,1998,29(3):A724-A727. 被引量:1

共引文献19

同被引文献72

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部